Skip to main content

Table 1 Clinical characteristics and circulating endothelial progenitor cells (EPC) levels of ovarian cancer patients

From: Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer

Clinical characteristic

Patients (n)

EPCs (per ml)

P

Age

  

NS

   <43 years old

17

1154 ± 93.7

 

   ≥43 years old

25

1205 ± 178.5

 

Residual tumor size

  

0.029

   <2 cm

22

523 ± 92.6

 

   ≥2 cm

8

875 ± 192.6

 

FIGO stage

  

0.034

   I--II

8

1023 ± 104.2

 

   III--IV

34

1450 ± 206.5

 

Histological subtype

  

NS

   Serous

23

1165 ± 254.6

 

   Mucinous

13

1187 ± 223.7

 

   Endometrioid

6

1235 ± 198.4

 

Therapy

  

NS

   Chemotherapy

12

783.4 ± 162.5

 

   Surgery

30

605 ± 147.2

 
  1. FIGO, Federation of Obstetrics and Gynecology; NS, not significant. Data are expressed as mean ± SE.